Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Fosun Pharma to repurchase H shares with proposed amount up to $1 billion
Fosun Pharma (2196) announced plans to repurchase H shares of the company, with the proposed total amount of funds for repurchasing H Shares of up to HK$1 billion. SCROLL TO CONTINUE WITH CONTENT The use of such repurchased H shares will be decided…
Avalyn Pharma Inc. (NASDAQ:AVLN) Given Average Rating of 'Moderate Buy' by Brokerages
Shares of Avalyn Pharma Inc. (NASDAQ:AVLN - Get Free Report) have received an average rating of 'Moderate Buy' from the six ratings firms that are covering the company, MarketBeat.com reports. One equities research analyst has rated the stock with…
Bank of New York Mellon Corp Buys New Position in Urogen Pharma $URGN
Bank of New York Mellon Corp purchased a new position in shares of Urogen Pharma (NASDAQ:URGN - Free Report) during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional…
Stocks to watch, Sept 7: 3 Tata group cos, 4 Railway stocks, 2 shipping sector, 3 Pharma majors, Adani Enterprises, NMDC, SJVN, Nava, Stanley Lifestyle will remain in focus
HyperVault, a subsidiary of Tata Consultancy Services (TCS), on Saturday announced that it has secured 264 acres of land in Hyderabad to develop a large-scale artificial intelligence data centre campus with a total investment outlay of up to Rs…
Seoul shares sharply up late Monday morning on strong chip gains
Korean stocks traded sharply higher late Monday morning as investors scooped up semiconductor shares on optimism on further artificial intelligence (AI)-related demand. Opening 3.34 percent higher, the benchmark Korea Composite Stock Price Index…
The Hard COVID Questions That Protect Pharma
The most important person in a pharmaceutical company may be the one willing to say no (timecodes below). That is what I took from my latest conversation with Susan F. Langlois, a retired vaccine-industry regulatory affairs specialist with…
Invesco Mortgage Capital Remains A High-Yield REIT Idea, As MBS Portfolio Grows (NYSE:IVR)
Albert Anthony is the pen name of a business author on Amazon and his newest book is 'How To Pick Stocks: 8 Steps For Long-Term Investing with Fundamental & Technical Analysis,' now available as a 2026 edition paperback and Kindle ebook in several…
Here's Why Billionaires Stanley Druckenmiller and Ken Griffin Are Loading Up on Eli Lilly Stock
The adage that 'birds of a feather flock together' doesn't always apply to billionaire investors. Most of these super-successful individuals have their own unique strategies that are highly differentiated from other approaches. However, that…
Patient safety in a time of fakes, misbrands and recalls
August proved a troubling month for patient safety — with at least four separate reports related to fake medicines, voluntarily recalls and alleged misbranding. An inter-State fake drugs network was busted after counterfeit blood pressure…
All in a day's reading, if you're following innovation
One problem with following innovation is that the extraordinary now arrives disguised as the weekly. A frontier model trained on more than 100,000 GPUs, several leading AI services stumbling in the same morning, a camera-chip company redesigning…
Saudi Central Bank Increases Stock Position in Pfizer Inc. $PFE
Saudi Central Bank raised its stake in Pfizer Inc. (NYSE:PFE - Free Report) by 23.9% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 976,902 shares…
Marco Brenner triumphs on stage 14 summit finish at the Vuelta a España as Enric Mas strengthens GC lead
Another challenging mountaintop finish saw Marco Brenner (Tudor Pro Cycling) emerge victorious atop the Sierra de la Pandera on stage 14 of the Vuelta a España. The German rider faced stiff competition from the current polka-dot jersey…
Financial analyst on ECB hike: Interest rates are rising... what should you do?
DONE WELL, CENTRAL banking is pretty bland stuff. No surprises. Such is the case for next week's European Central Bank announcement on interest rates. The people in grey suits are scheduled to spend two days in meetings, emerging at lunchtime on…
Moderna Just Doubled Overnight, and 2 More Healthcare Stocks Could Follow It
Drug pricing is back on the front page, and healthcare investors have barely flinched. The White House's latest round of most-favored-nation pricing agreements brought nine more manufacturers into the fold, pushing the total to 26 companies…
Lantheus Holdings, Inc. (NASDAQ:LNTH) Receives Consensus Recommendation of 'Hold' from Brokerages
Shares of Lantheus Holdings, Inc. (NASDAQ:LNTH - Get Free Report) have received a consensus recommendation of 'Hold' from the fourteen brokerages that are presently covering the stock, MarketBeat.com reports. Ten investment analysts have rated the…
Receive a Daily briefing on Pharma Industry News
Get Started